Skip to main content
. 2015 Dec 10;10(12):e0144144. doi: 10.1371/journal.pone.0144144

Table 1. Correlation between clinicopathologic features and SGR.

Result, n = 958 Mean SGR 1 (x10-2) p-value 2 Low SGR1 (x10-2) (<0.59) High SGR1 (x10-2) (>0.59) p-value 3
Age at diagnosis ≤30 11 3.26 0.272 3 (0.6) 8 (1.7) 0.626
31–40 129 1.04 69 (14.4) 60 (12.6)
41–50 349 1.00 178 (37.2) 171 (35.8)
51–60 282 1.21 138 (28.8) 144 (30.1)
61–70 157 1.14 78 (16.3) 79 (16.5)
71≤ 29 1.09 13 (2.7) 16 (3.3)
US interval (days) 8–18 232 1.41 0.069 127 (26.5) 105 (22.0) 0.333
19–28 277 1.32 131 (27.3) 146 (30.5)
29–40 218 0.78 111 (23.2) 107 (22.4)
41 - 230 0.91 110 (23.0) 120 (25.1)
1 st US size (cm) ≤ 1 170 2.10 < 0.001 77 (16.1) 93 (19.5) 0.104
>1, ≤ 1.5 258 1.34 119 (24.8) 139 (29.1)
>1.5, ≤ 2 217 0.98 112 (23.4) 105 (22.0)
> 2 312 0.50 171 (35.1) 141 (29.5)
Axillary Lymph Node status Negative 621 1.02 0.170 332 (69.3) 289 (60.5) 0.004
Positive 336 1.30 147 (30.7) 189 (39.5)
Tumor Grade (n = 895) Grade 1,2 478 1.09 0.735 263 (58.4) 215 (48.3) 0.002
Grade 3 417 1.16 187 (41.6) 230 (51.7)
Lymphovascular Invasion (n = 884) Negative 550 0.85 0.006 298 (67.3) 252 (57.1) 0.002
Positive 334 1.40 145 (32.7) 189 (42.9)
Ki-67 (n = 941) < 10% 733 1.09 0.650 377 (80.0) 356 (75.7) 0.112
≥ 10% 208 1.19 94 (20.0) 114 (24.3)
Hormone Receptor Positive 697 1.18 0.330 354 (73.9) 343 (71.8) 0.455
Negative 260 0.96 125 (26.1) 135 (28.2)
Subtype (n = 952) Luminal 697 1.18 0.627 354 (74.4) 343 (72.1) 0.569
HER2 67 0.99 34 (7.1) 32 (6.7)
TNBC 189 0.95 88 (18.5) 101 (21.2)

1 SGR Specific Growth Rate, US Ultrasonography

2 p values are from T-test & ANOVA test

3 p values are from χ2 test